mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.094 |
0.06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.06 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.06 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.31 |
0.06 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.06 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.06 |